# Laurence Collette

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/laurence-collette/

## Facts

| Field | Value |
| --- | --- |
| Citations | 49,479 |
| Field | Prostate Cancer Treatment and Research |
| h-index | 97 |
| i10-index | 233 |
| Last Known Institution | GlaxoSmithKline (Belgium) |
| OpenAlex ID | https://openalex.org/A5082944210 |
| ORCID iD | https://orcid.org/0000-0003-2518-7281 |
| Works | 432 |

## Researcher papers

- [Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation](https://scholariq.org/papers/characterisation-and-classification-of-oligometastatic-disease-a-european/)
- [Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial](https://scholariq.org/papers/long-term-efficacy-of-early-versus-delayed-radiotherapy-for-low-grade/)
- [Nomograms for Predicting Local Recurrence, Distant Metastases, and Overall Survival for Patients With Locally Advanced Rectal Cancer on the Basis of European Randomized Clinical Trials](https://scholariq.org/papers/nomograms-for-predicting-local-recurrence-distant-metastases-and-overall/)
- [Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group](https://scholariq.org/papers/meta-analysis-of-chemotherapy-in-head-and-neck-cancer-mach-nc-an-update-on-107/)
- [Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis](https://scholariq.org/papers/role-of-radiotherapy-fractionation-in-head-and-neck-cancers-march-an-updated/)
- [Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial](https://scholariq.org/papers/oxaliplatin-fluorouracil-and-leucovorin-with-or-without-cetuximab-in-patients/)

## Researcher topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Advanced Radiotherapy Techniques](https://scholariq.org/topics/advanced-radiotherapy-techniques/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)

## Researcher university

- [GlaxoSmithKline (Belgium)](https://scholariq.org/institutions/glaxosmithkline-belgium/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.